Harvard Professor and ARI shares photobiomodulation treatment insights
World expert Harvard Associate Professor Michael Hamblin recently visited the San associated Australasian Research Institute to discuss photobiomodulation therapy being investigated for treatment of degenerative diseases like Parkinson’s and Alzheimer’s.
Photobiomodulation is a low level light therapy using red or near-infrared light to stimulate, heal, regenerate and protect injured or degenerating tissue.
Concluding the discussions and tour, Institute Director Associate Professor Dr Ross Grant and Director of Photomolecular research Dr Ann Liebert presented Associate Professor Hamblin with a compilation of research works undertaken by the ARI.
Dr Liebert is conducting research into uses of the therapy.
Associate Professor Hamblin’s speaking tour also including addressing Grand Rounds at Royal Melbourne Hospital and to a Parkinson’s South Australia meeting.
Associate Professor Hamblin with Dr Ann Liebert, Researcher Dr Lucy Arshynnikova and Dr Brian Bicknell, with equipment including protective light therapy glasses worn during treatment.
ARI Associate Director Ross Grant, Director Photomolecular Research Dr Liebert, with Associate Professor Hamblin.
Dr Liebert showing Associate Professor Hamblin the Photobiology Lab within the ARI.